ESH Young Investigator
Obesity Paradox: Primary PCI Particularly Safe for Obese

In recent years (if ever) there hasn’t been a lot of encouraging health news for the obese. While there may be specific pros and cons related to the health consequences of variables such as age, race, gender, and even dietary habits (chocolate and wine come immediately to mind), there has been a dearth of positive news regarding just about any aspect of obesity.

MORE>>

BP treatment
Older Patients Benefit from Direct Renin Inhibitor

The direct renin inhibitor aliskiren combined with valsartan, an angiotensin receptor blocker, provides significantly greater systolic blood pressure (BP) reduction than valsartan monotherapy in older patients.

MORE>>

Marker
Cystatin C a Marker of CV and Metabolic Syndrome Risk in Hypertensive Patients

Produced by all types of human nucleated cells, cystatin C is a serum protein found in virtually all tissues and bodily fluids. Levels of cystatin C are independent of height, weight, muscle mass, age, and gender.

MORE>>

LIPGENE dietary intervention study
The effect of dietary fatty acids on blood pressure in subjects with metabolic syndrome

Altering the quantity and quality of dietary fatty acids may influence blood pressure (BP) in subjects with metabolic syndrome. Among men in particular, new data from LIPGENE suggest that some fats increase systolic BP and pulse pressure while others have the opposite effect.

MORE>>

Health challenge
Global Solution Needed for Global Burden of CVD

Cardiovascular disease (CVD), once considered a disease of affluence, now reaches into all corners of the globe. It is increasingly among the leading causes of death among middle-income and developing countries: for example, death due to CVD affects 52% of individuals younger than 70 in India compared to 23% in countries with established market economies.

MORE>>

ESH Presidential Lecture
Measurement of aortic stiffness

Recent studies showed a close relationship between microvascular damage in brain and kidney and either pulse pressure or arterial stiffness. In breaking the vicious circle between small and large artery damage not all substances are equally good, as say Prof. Stéphan Laurent, MD, ESH president in the ESH Presidential Lecture.

MORE>>